Quanterix QTRX
NASDAQ QTRX
$3.12 +0.16 (+5.42%)
As of: Aug 20, 2026 · 3:59 PM EDT

Quanterix (QTRX) Total Non-Current Liabilities (2017 - 2026)

Quanterix's (QTRX) quarterly Total Non-Current Liabilities came in at $81.0 million in Q1 2026, up 5.98% YoY from $76.4 million in Q1 2025, and down 29.54% on a QoQ basis from $114.9 million in Q4 2025.

Quanterix (QTRX) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

Quanterix (QTRX) has 10 years of Total Non-Current Liabilities data on file, last reported at $81.0 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 5.98% year-over-year to $81.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $81.0 million (up 5.98% YoY) and the FY2025 annual result came in at $114.9 million, up 50.26% from the prior year.
  • Total Non-Current Liabilities slipped to $81.0 million in Q1 2026, from $114.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $122.3 million in Q3 2025 to a low of $69.3 million in Q1 2023.
  • A 5-year average of $80.5 million and a median of $76.4 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities retreated 9.96% — and 2025, when it jumped 71.81%.
  • Tracing QTRX's Total Non-Current Liabilities over 5 years: stood at $74.2 million in 2022, then climbed by 4.38% to $77.4 million in 2023, then retreated by 1.21% to $76.5 million in 2024, then surged by 50.26% to $114.9 million in 2025, then declined by 29.54% to $81.0 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $81.0 million (Q1 2026), $114.9 million (Q4 2025), and $122.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 21.28 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 9.07 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 3.44 Bn
10 Quanterix 146.22 Mn 52.69 Mn 12.67 Mn 78.59 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 78.59 Mn
Mar 31, 2026 80.99 Mn
Dec 31, 2025 114.94 Mn
Sep 30, 2025 122.31 Mn
Jun 30, 2025 82.36 Mn
Mar 31, 2025 76.42 Mn
Dec 31, 2024 76.50 Mn
Sep 30, 2024 71.19 Mn
Jun 30, 2024 74.12 Mn
Mar 31, 2024 69.77 Mn
Dec 31, 2023 77.43 Mn
Sep 30, 2023 75.33 Mn
Jun 30, 2023 73.29 Mn
Mar 31, 2023 69.31 Mn
Dec 31, 2022 74.18 Mn
Sep 30, 2022 72.71 Mn
Jun 30, 2022 81.40 Mn
Mar 31, 2022 76.54 Mn
Dec 31, 2021 58.54 Mn
Mar 31, 2021 58.82 Mn